It has been shown in AML that IDH1 R132 and IDH2 R140 or R172 lead to the conversion of α-keto-glutarate to 2-hydroxy-glutarate, which leads to the inhibition of TET2 with similar effects on the methylation and transcription profiles [85]. Here, IDH1 is linked to acute myeloid leukemia.